American Vanguard (AVD) Downgraded by Zacks Investment Research to “Sell”

American Vanguard (NYSE:AVD) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report released on Tuesday, November 14th.

According to Zacks, “AMERICAN VANGUARD CORP. is a holding company, which through its subsidiaries, is engaged in the manufacturer and formulation of chemicals for crops, human and animal health protection. These chemicals which include insecticides, fungicides, molluscicides, growth regulatorsain, and soil fumigants, are marketed in liquid, powder, and granular forms. “

AVD has been the subject of a number of other reports. Piper Jaffray Companies reiterated a “hold” rating and issued a $23.00 price target on shares of American Vanguard in a report on Friday, November 3rd. BidaskClub upgraded American Vanguard from a “strong sell” rating to a “sell” rating in a research report on Thursday, August 10th. Finally, Roth Capital set a $28.00 price target on American Vanguard and gave the stock a “buy” rating in a research report on Sunday, October 1st. Two analysts have rated the stock with a sell rating, one has issued a hold rating, one has given a buy rating and one has assigned a strong buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus target price of $25.33.

American Vanguard (AVD) remained flat at $$19.90 during mid-day trading on Tuesday. The company had a trading volume of 60,682 shares, compared to its average volume of 104,633. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.20 and a current ratio of 2.37. American Vanguard has a twelve month low of $14.65 and a twelve month high of $24.00. The company has a market capitalization of $592.92, a PE ratio of 36.85, a P/E/G ratio of 2.24 and a beta of 1.24.

American Vanguard (NYSE:AVD) last issued its quarterly earnings results on Thursday, November 2nd. The basic materials company reported $0.14 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.17 by ($0.03). American Vanguard had a net margin of 4.83% and a return on equity of 5.44%. The firm had revenue of $90.00 million during the quarter, compared to the consensus estimate of $89.17 million. During the same quarter last year, the firm posted $0.10 earnings per share. American Vanguard’s revenue was up 9.2% compared to the same quarter last year. research analysts anticipate that American Vanguard will post 0.59 EPS for the current fiscal year.

Several institutional investors have recently made changes to their positions in AVD. Prudential Financial Inc. lifted its holdings in shares of American Vanguard by 0.3% in the first quarter. Prudential Financial Inc. now owns 43,710 shares of the basic materials company’s stock valued at $726,000 after buying an additional 150 shares during the period. OppenheimerFunds Inc. raised its position in shares of American Vanguard by 53.2% during the first quarter. OppenheimerFunds Inc. now owns 15,709 shares of the basic materials company’s stock worth $261,000 after purchasing an additional 5,456 shares during the period. Principal Financial Group Inc. raised its position in shares of American Vanguard by 3.6% during the first quarter. Principal Financial Group Inc. now owns 196,379 shares of the basic materials company’s stock worth $3,260,000 after purchasing an additional 6,903 shares during the period. Wellington Management Group LLP raised its position in shares of American Vanguard by 143.2% during the first quarter. Wellington Management Group LLP now owns 25,524 shares of the basic materials company’s stock worth $423,000 after purchasing an additional 15,028 shares during the period. Finally, Teachers Advisors LLC raised its position in shares of American Vanguard by 2.7% during the first quarter. Teachers Advisors LLC now owns 50,213 shares of the basic materials company’s stock worth $834,000 after purchasing an additional 1,323 shares during the period. Institutional investors and hedge funds own 76.36% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This piece was originally published by BBNS and is the sole property of of BBNS. If you are accessing this piece on another site, it was illegally copied and reposted in violation of U.S. & international trademark and copyright legislation. The correct version of this piece can be viewed at https://baseballnewssource.com/markets/zacks-investment-research-lowers-american-vanguard-corporation-avd-to-sell/1782852.html.

About American Vanguard

American Vanguard Corporation operates as a holding company. The Company conducts its business through its subsidiaries, AMVAC Chemical Corporation (AMVAC), GemChem, Inc (GemChem), 2110 Davie Corporation (DAVIE), Quimica Amvac de Mexico SA de C.V. (AMVAC M), AMVAC Mexico Sociedad de Responsabilidad Limitada (AMVAC M Srl), AMVAC de Costa Rica Sociedad de Responsabilidad Limitada (AMVAC CR Srl), AMVAC Switzerland GmbH (AMVAC S), AMVAC do Brasil Representacoes Ltda (AMVAC B), AMVAC C.V.

Get a free copy of the Zacks research report on American Vanguard (AVD)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for American Vanguard Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Vanguard Corporation and related companies with our FREE daily email newsletter.

 


Latest News

Tigers Trade Ian Kinsler to Angels for Pair of Minor Leaguers
Tigers Trade Ian Kinsler to Angels for Pair of Minor Leaguers
Manny Machado Could Change Positions or Uniforms
Manny Machado Could Change Positions or Uniforms
Jack Morris, Alan Trammel Voted by Modern Era Committee into Hall of Fame
Jack Morris, Alan Trammel Voted by Modern Era Committee into Hall of Fame
Yankees and Marlins Continue Stanton Trade Talks
Yankees and Marlins Continue Stanton Trade Talks
Marlins Making Moves, Trade Dee Gordon to Seattle
Marlins Making Moves, Trade Dee Gordon to Seattle
Report: Astros Dallas Keuchel Pitched With Injured Foot
Report: Astros Dallas Keuchel Pitched With Injured Foot


Leave a Reply

 
© 2006-2017 BBNS.